GastroPanel is a patient-friendly blood test for assessing the structure and function of the stomach in patients with Dyspepsia. It is a simple and painless means to find out whether an individual has a healthy or atrophied stomach mucosa.
In primary care stomach problems present as pain or discomfort, heartburn, a feeling of heaviness, bloating, nausea or vomiting. And sometimes, even severe conditions that require medical attention, can be asymptomatic.
GastroPanel is a blood test that GPs use to support the diagnosis and referral of patients with stomach symptoms It is suitable for all adults suffering from gastric complaints and diagnoses Atrophic Gastritis as well as Helicobacter pylori.
Left untreated, Helicobacter pylori and atrophic gastritis can progress to gastric cancer through a sequence of mucosal changes (Correa's Cascade). It is therefore important to exclude atrophic gastritis early as part of routine investigations for dyspepsia.
What does GastroPanel detect?
GastroPanel® is intended as the first-line diagnostic test for dyspeptic complaints to detect Helicobacter pylori infection and atrophic gastritis (mucosal atrophy) caused by Helicobacter pylori or autoimmune disease.
The GastroPanel test also informs the the doctor about risks associated with atrophic gastritis (e.g. gastric and oesophageal cancer) as well as malabsorption of vitamin B12, calcium, magnesium, zinc, iron and certain medicines.
GastroPanel reveals the stomach's capacity for producing acid so when it comes to prescribing antacids such as PPIs and H2RAs the physician can evaluate the need for such drugs. For example, GastroPanel identifies corpus atrophic gastritis, a condition that impedes gastric acid production in the stomach. Therefore antacid therapy in such individuals is contraindicated.
Select and prioritise Gastroscopy
Diagnose high risk conditions
Confirm need for PPI therapy
For GP and Specialist use
Diagnose Dyspepsia with GastroPanel™
When patients present with dyspepsia and stomach complaints use GastroPanel as a first line test to diagnose Helicobacter pylori and atrophic gastritis prior to prescribing PPIs or referral for gastroscopy.
GastroPanel is a simple, effective and low cost test that reveals the health and status of the gastric mucosa and informs them about the risks assiciated with the findings. This enables doctors to formulate appropriate and effective treatment plans for their patients including eradication therapy, referral for further investigation, or prescribing advice for antacids.
Ways to test your patients using GastroPanel
Frequently asked Questions
What is atrophic Gastritis and why is it important to test for it?
Is GastroPanel for GPs (Primary Care) or Specialists (Secondary Care)?
What does GastroPanel measure in blood?
What information is included in my report?
How does GastroPanel fit into current guidance and guidelines?
How accurate is GastroPanel?
BIOHIT HealthCare in Reflux and Dyspepsia
Millions of people in the UK and worldwide suffer from non-specific gastroesophageal symptoms which are challenging for the treating physician to manage. BIOHIT HealthCare has academic interest in dyspepsia as well as a commercial role in supplying innovative test systems to help physicians diagnose and monitor dyspepsia and associated diseases.
BIOHIT HealthCare supplies essential tests that help investigate dyspepsia in Primary and Secondary Care, helping treating physicians to adopt a test-and -treat or test-and-refer strategy to improve their practice. With BIOHIT's non-invasive GastroPanel and Peptest diagnostic tests, the treating physician can determine the health and function of the stomach prior to treating, and, gain a clear understanding of the involvement of acid and pepsin. The tests help physicians decide whether the patient should be referred to Secondary Care for further investigation or treated in Primary Care with confidence.